| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/03/2009 | WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof |
| 12/03/2009 | WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | WO2009143689A1 A soluble tumor necrosis factor receptor mutant |
| 12/03/2009 | WO2009125409A3 Fatty acid amides and uses thereof |
| 12/03/2009 | WO2009119987A3 Composition comprising pyrazole derivatives for preventing or treating osteoporosis |
| 12/03/2009 | WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 12/03/2009 | US20090298856 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1) |
| 12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
| 12/03/2009 | US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298838 Method for Determination of Effective Dose of Methotrexate |
| 12/03/2009 | US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof |
| 12/03/2009 | US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/03/2009 | US20090298777 Spinal fusion methods and devices |
| 12/03/2009 | US20090298761 Methods of treating cartilage defects using a soluble morphogenic protein complex |
| 12/03/2009 | US20090297606 Gamma-lactam compounds for promoting bone growth |
| 12/03/2009 | US20090297605 Composition And Device For In Vivo Cartilage Repair |
| 12/03/2009 | US20090297588 Antibiotic dressing for the treatment of infected wounds |
| 12/03/2009 | US20090297535 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling |
| 12/03/2009 | US20090297475 Cysteine dioxygenase polymorphisms |
| 12/03/2009 | CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof |
| 12/03/2009 | CA2710040A1 A soluble tumor necrosis factor receptor mutant |
| 12/02/2009 | EP2128260A2 Modified TGF-beta superfamily proteins |
| 12/02/2009 | EP2128253A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
| 12/02/2009 | EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 12/02/2009 | EP2128136A1 2-phenylnicotinic acid derivative |
| 12/02/2009 | EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 12/02/2009 | EP2127681A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 12/02/2009 | EP2127662A1 Rankl production inhibitor |
| 12/02/2009 | EP2127656A1 Compositions of risedronate and vitamin d3 |
| 12/02/2009 | EP2125816A2 Metalloprotease inhibitors containing a heterocyclic moiety |
| 12/02/2009 | EP2125719A1 Bazedoxifene bis-phosphorates |
| 12/02/2009 | EP2125009A1 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 12/02/2009 | EP2124997A2 Use of il-1 antagonists to treat gout and pseudogout |
| 12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 12/02/2009 | EP2124943A1 Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors |
| 12/02/2009 | EP2124919A2 Methods for modulating bone formation and mineralization |
| 12/02/2009 | EP2124552A1 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 12/02/2009 | EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
| 12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 12/02/2009 | EP1248804B2 Recombinant antibodies to human interleukin-1 beta |
| 12/02/2009 | CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 12/02/2009 | CN101594859A Compositions comprising carnosic acid 12-methylether |
| 12/02/2009 | CN101591388A Soluble tumor necrosis factor (TNF) receptor mutant |
| 12/02/2009 | CN101591324A Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 12/02/2009 | CN101591323A Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 12/02/2009 | CN101591321A Method for preparing 5,6,7,4'-tetrahydroxyflavone and application of 5,6,7,4'-tetrahydroxyflavone in medicaments |
| 12/02/2009 | CN101591227A Cinnamyl alcohol derivatives, preparation method thereof and pharmaceutical use thereof |
| 12/02/2009 | CN101590236A Composition containing calcium antagonist and Statins and application thereof |
| 12/02/2009 | CN101590208A Medicament composition for treating rheumatoid arthritis, and preparation method thereof |
| 12/02/2009 | CN101590185A Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof |
| 12/02/2009 | CN101590184A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590183A Application of medicinal composition in preparing medicaments for treating fracture |
| 12/02/2009 | CN101590171A Chinese medicinal composition for treating acute ankle sprain |
| 12/02/2009 | CN101590169A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590168A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590167A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590166A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590159A External medicament for treating ankylosing spondylitis and proliferative arthritis and processing method thereof |
| 12/02/2009 | CN101590151A Chinese medicament for curing bone covering tumor |
| 12/02/2009 | CN101590147A Chinese medicinal composition for treating cervical and lumbar diseases and preparation method thereof |
| 12/02/2009 | CN101590146A Chinese medicinal composition for treating cervical and lumbar diseases |
| 12/02/2009 | CN101590136A Application of traditional Chinese medicine composition in preparing medicament for treating hyperosteogeny |
| 12/02/2009 | CN101590119A Chinese medicament for treating arthrosynovitis |
| 12/02/2009 | CN101590110A Method for extracting bioflavonoid from mulberry |
| 12/02/2009 | CN101590109A Compound preparation for treating back pain caused by senile osteoporosis and preparation method thereof |
| 12/02/2009 | CN101590036A Application of epoxydiene taken as inhibitor of proinflammatory mediators |
| 12/02/2009 | CN101589898A Multifunctional health care Chinese medicament pillow |
| 12/02/2009 | CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 12/02/2009 | CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof |
| 12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 12/02/2009 | CN100563675C Safflower wine |
| 12/02/2009 | CN100563674C Double sticking double effect plaster for internal and external combined treatment |
| 12/02/2009 | CN100563667C Medicine for treating tracheitis and rheumatic arthritis |
| 12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 12/01/2009 | US7625934 Metalloproteinase inhibitors |
| 12/01/2009 | US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625890 Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors |
| 12/01/2009 | US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 12/01/2009 | US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections |
| 12/01/2009 | US7625562 Generation of cartilage using magnetizable particles |
| 12/01/2009 | CA2461100C 4-imidazolin-2-one compounds |
| 12/01/2009 | CA2432121C Nitric oxide synthase inhibitor phosphate salt |
| 11/26/2009 | WO2009143363A2 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators |
| 11/26/2009 | WO2009143064A2 Rice bran extracts for inflammation and methods of use thereof |
| 11/26/2009 | WO2009143024A2 Compounds and methods for kinase modulation, and indications therefor |
| 11/26/2009 | WO2009143020A1 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
| 11/26/2009 | WO2009143018A2 Compounds and methods for kinase modulation, and indications therefor |
| 11/26/2009 | WO2009142321A1 Novel thiophenediamine derivative having urea structure |
| 11/26/2009 | WO2009142195A1 Agent for induction/maintenance of remission |
| 11/26/2009 | WO2009140863A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 11/26/2009 | WO2009123948A3 Compounds and compositions as itpkb inhibitors |
| 11/26/2009 | WO2009104913A3 Composition comprising an extract of mixed herbs with lonicera japonica thunb and anemarrhena asphodeloides bunge for preventing and treating arthritic diseases |
| 11/26/2009 | WO2008124907A8 Resveratrol-containing composition for modulating bone formation |